A61K 35/545
Embryonic stem cells
Official title: Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
A61K35/545 (Embryonic stem cells) appears on 632 US grants and 1,580 published applications in this corpus.
Search patents in A61K- Granted patents
- 632
- Published applications
- 1,580
- Assignees
- 673
- Inventors
- 2,809
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 4 |
| 2003 | 3 | 7 |
| 2004 | 0 | 10 |
| 2005 | 1 | 14 |
| 2006 | 2 | 13 |
| 2007 | 1 | 28 |
| 2008 | 1 | 17 |
| 2009 | 3 | 25 |
| 2010 | 7 | 24 |
| 2011 | 7 | 31 |
| 2012 | 13 | 50 |
| 2013 | 12 | 54 |
| 2014 | 35 | 62 |
| 2015 | 31 | 79 |
| 2016 | 38 | 104 |
| 2017 | 42 | 80 |
| 2018 | 42 | 95 |
| 2019 | 46 | 98 |
| 2020 | 38 | 111 |
| 2021 | 50 | 128 |
| 2022 | 49 | 139 |
| 2023 | 45 | 125 |
| 2024 | 49 | 113 |
| 2025 | 71 | 96 |
| 2026 | 42 | 73 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Extracellular vesicles from stem cells to treat and/or prevent disease1 Sep 2026US 12,721,867 B2Children’s Hospital Los Angeles
- Modulation of splenocytes in cell therapy1 Sep 2026US RE51,018 E1Board of Regents, The University of Texas System
- Diagnostic and drug screening for molecular signatures of early onset sporadic parkinson's disease18 Aug 2026US 12,708,611 B2Cedars-Sinai Medical Center
- Mechanical and biochemical activation and control of skeletal stem cells for cartilage regeneration28 Jul 2026US 12,691,161 B2The Board of Trustees of the Leland Stanford Junior University
- Method to improve therapeutic properties of stem cells14 Jul 2026US 12,678,466 B2Atomic Energy of Canada Limited/éNergie Atomique Du Canada LimitéE
- Methods of preventing on-target genotoxicity induced by nucleases8 Oct 2026US 2026/0306552 A1Chu De Bordeaux
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Mechanical and biochemical activation and control of skeletal stem cells for cartilage regeneration1 Oct 2026US 2026/0295008 A1
- Ribosomal Remodeling in Diabetes1 Oct 2026US 2026/0295074 A1Joslin Diabetes Center, Inc.
- Cell1 Oct 2026US 2026/0297622 A1Antion Biosciences SA
Most cited
By later US patents
- Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood229US 5,004,681 ABiocyte Corporation · 1991
- Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells185US 7,311,905 B2Anthrogenesis Corporation · 2007
- Redirection of cellular immunity by receptor chimeras135US 7,049,136 B2The General Hospital Corporation · 2006
- Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells108US 5,851,828 AThe General Hospital Corporation · 1998
- Method of organogenesis and tissue regeneration/repair using surgical techniques106US 6,227,202 B1Maulana Azad Medical College · 2001